THE APPEARANCE of insecticide resistance in a population is usually detected with one or more of three techniques. The traditional approach uses complete dose-response tests with 4-5 doses that produce 10-90% mortality. Resistance is expressed in terms of the ratio of the LD50 or LDs<; of the resistant strain to that of the susceptible strain. Alternatively, one dose is often used and the mortalities of the susceptible and test strains are compared. This approach is called the discriminating or diagnostic dose test. The term discriminating dose is properly used when enough genetic and toxicological evidence has accumulated that shows that a dose causes a different response between genotypes. Diagnostic dose is a less rigorous term and is used when one wants to monitor resistance but is less certain that the dose does separate genotypes. The third choice for detecting resistance is to use one of the small-scale biochemical assays or techniques from molecular biology that have been adapted to measure the frequency of specific resistance mechanisms in populations (Hemingway et a1. 1986 , Brown & Brogdon 1987 . These elegant assays are currently of limited value in monitoring the initial development of resistance, because years of research are required for selection of homozygous resistant strains and assay optimization and validation.
An extensive body of literature about the statis-tical treatment of data for prohit analysis of susceptible strains was reviewed by Finney (1971) . Toxicities of different xenobiotics can be compared with probit regression. Investigations of the requirements for reliable estimation of dose-response regressions for insecticides have emphasized criteria for precise comparisons. Robertson et al. (1984) , for example, investigated optimal sample size and dose selection necessary to produce precise lethal dose estimates in typical bioassays. Although the concept of discriminating doses has been used for many years (see Brown & Pal 1971) , its statistical limitations have been investigated only recently.
The scientist who suspects that resistance is present must choose between estimation of complete dose-response lines or use of a single-dose test. Disadvantages of complete dose-response lines include being time-consuming and insensitive to slight changes in resistance gene frequencies, especially at the LDso. Because of the wide fiducial limits at the LD!i5 and higher, determining whether resistance exists based on differences at the LD!i5 can be ambiguous or misleading. Roush & Miller (1986) described some of the advantages of the discriminating dose technique. The primary advantage is speed: Because fewer individuals must be tested, more populations can be tested. They divided diagnostic dose tests into two categories (perfect and nonperfect) depending on whether the dose killed all susceptible insects and no resistant ones (perfect) or killed both genotypes (nonperfect).
In many instances, perfect discriminating doses have provided useful data for genetic studies. Most notably, this has occurred when organophosphorus or cyclodiene insecticides have been used because Vol. 83, no. 4 resistance levels are generally high and inherited in a codominant to dominant manner. For most situations, some caution must be used before the technique is applied. Unfortunately, the genetics and toxicology of resistance are understood for few species. Therefore, the researcher does not know whether a discriminating dose exists. Extrapolation from work on other species is sometimes used as an indicator of the level of resistance, type of re~ sistance and mode of inheritance which might be expected in a homozygous strain. Extrapolation between laboratory strains and field strains is tenuous because of natural variation in sensitivity between populations. Should a field population be less sensitive than a laboratory strain, lower mortality might occur at a supposed discriminating dose when in fact the survival would be due to natural variation in response within the field population. Based on these reasons alone, use of the diagnostic dose approach to monitor resistance might not be wise if that resistance is not well understood. Dennehy et a1. (1983) indicated the dangers of arbitrarily choosing a dose several times higher than the LD\ZI' For mites resistant to dicofol, use of such a dose resulted in an underestimate of resistance because a large proportion of the resistant mites also were killed by this dose. By lowering the dose and changing the test technique, they were better able to estimate the resistant population. Roush & Miller (1986) briefly considered the subject of low versus high diagnostic doses. Their concern was that high doses inevitably have a higher estimation error. A lower dose would then be better based on its intrinsically improved accuracy. However, this effect is mitigated by the increased sample size.
Neither Dennehy et a1. (1983 ) nor Roush & Miller (1986 addressed the central question of how to determine the correct dose with which to test a putatively resistant strain. In a perfect scenario, all doses that kill all susceptible insects exclusively are equivalent. Under the nonperfect scenario, choosing the dose is less straightforward because an accurate estimation of the susceptible strain's mortality at the discriminating dose is required.
In this paper, we describe an approach for improving the probability of detecting resistance based on finding the best diagnostic dose. This approach measures the statistical confidence. or power. we could have in detecting a difference in mortality of the susceptible and test strains that might be due to resistance. Statistically. the accuracy or power of the test is calculated at various conditions that can be changed. For testing two strains, large-sample statistical theory assures us that the most powerful tests are the X2 test for a two-tailed test, or the Z test for a one-tailed test (Lehmann 1959) . The actual power of these optimal tests, as influenced by all relevant factors, is the subject of this paper.
The power of a statistical test can be defined in a number of ways. According to Mendenhall & Schaeffer (1973) , power = 1 ~,where ~ is the probability of accepting the null hypothesis (H" mortality of the susceptible strain = mortality of the test strain) when it is false. In this sense. power is the probability that the test will reject the null hypothesis and is really only of interest when Ho is false. However, power is defined when the null hypothesis is true. in which case power equals the a level (where a is the probability of rejecting a true hypothesis). A much more valuable use of power occurs when Ho is false. In this case, power is the probability of correctly accepting the alternative hypothesis (H. lt : mortality of the susceptible strain *' mortality of test strain), i.e .• a difference in mortality exists between the two strains that might be due to resistance. To use the model we want it to predict conditions under which power will be maximized.
The Model
The model we used to calculate the power of diagnostic dose tests is based directly on the 2 x 2 contingency table in which the number of surviving and dead susceptible insects are compared with the numbers from the test strain with either the x' test (df = 1) or the Z test. The power of either of these tests is easily computed using SAS~PC Version 6.03 (SAS Institute 1987, 70) . When H, is false, the x'l statistic follows a noncentral X2 distribution (df = 1) with a noncentrality parameter, A. In SAS-PC. the noncentral X2 distribution is an interactive function. Le., for any value of X, SAS will calculate power.
To find A. we calculated the expected number of dead and ·alive insects for the treatment and used these numbers in the formula for the X2 statistic. The validity of this procedure to compute X2 test power has been shown by Drost et al. (1989) . To compare the two-tailed X2 test statistic with the one-tailed Z test favored by Roush & Miller (1986) , we noted that Z is the signed square root of the X2 test and Halt is rejected if Z exceeds the critical value of 1.645 (for a = 0.05). The probability distribution of the Z test is the normal distribution with mean vx. and a standard deviation of 1. Thus, the power of the one~tailed Z test is the probability that such a random variable exceeds 1.645.
Mortality of the susceptible strain was based on the calculated logit regression. given the slope and the LD 50 • "vVe characterized the resistance by calculating logit regression lines for fully resistant strains relative to the susceptible strains. Next. the mode of inheritance of the resistance was estab~ lished by placing the logit regression line between the homozygous susceptible and resistant lines. Finally. a test strain was synthesized in which a resistance gene existed in Hardy-"vVeinberg equilibrium. Mortality in the synthetic test strain at various doses was compared with mortality in the susceptible strain. Mortality of both strains was calculated at doses producing 0-99.9% mortality of the sus- ceptible strain. Survival of the two population.s was compared statistically as described above. This procedure was repeated as each parameter of interest was changed sequentially. A convenient way to visualize the dose is to view it in terms of toxic equivalents required to kill a certain proportion of the susceptible population. For computational simplicity, we assumed that slopes for the regression lines are equal. For ease of presenting the results, we classified variables affecting the power into three groups (operational, toxicological, and genetic) following the scheme of Georghiou & Taylor (1977) , who listed similar factors that influence the rate of resistance development. Parameters that we considered are listed and defined in List 1 according to whether they are toxicological, genetic, or operational. According to Georghiou & Taylor (1977) , only operational factors can be manipulated to make resistance develop faster or slower. Likewise, in our analysis only operational factors can be changed by researchers to increase the test's power. These factors are the number of susceptible insects tested (n,), the number of test strain insects tested (ll t ) and the dose (d [mortality of the susceptible strain]). The genetic factors are frequency of the resistance gene (p) and dominance of the resistance (gamma, ')'). Toxicological factors are resistance factor (.6, delta) and slope of the dose-response line. In one sense, genetic and toxicological factors are inherent to the insect and insecticide and cannot be changed. However, the magnitude of these factors certainly varies within insecticide classes and might offer some chance for manipulation. ""Ve examined the contribution of toxicological and genetic factors to determine if some situations were more likely to produce tests of high power.
Results
Our calculations are presented in two ways. As mentioned earlier, mortality in the test strains was determined relative to the mortality in the susceptible strain. In this manner, power could be directly related to dose. The second method was to plot maximal power (MaxPower) as a dependent variable. MaxPower is the highest power found for a specified set of conditions over the range of doses producing 0-99.5% mortality of the susceptible strain. j'v!axPower provides useful comparisons of the effects of multiple variables. As shown in Fig.  1 , MaxPower for a slope of 3.3 was 0.35. ""Ve refer to the optimal dose that produces MaxPower as dopl" As will be shown later, dc"Pl varies depending on the magnitude of the parameters. The following results are based on selected parameter values chosen to illustrate each relationship.
Comparison of X2 and One-Tailed Z Tests. Of obvious interest is the effect of the statistical test used. In earlier versions of our program, we used a X2. test to generate power because our interest then was in d~ffl more than the value of power. In an earlier draft of this manuscript, two anonymous reviewers indicated that a one-tailed Z test would be better because the X2 test is two tailed. ""V hen monitoring populations for resistance, we are not interested in significance of results in which the mortality of the test strain is greater than that of the ~llsceptible strain. In our opinion, use of a onetailed Z test is preferable .
In this series of calculations, each parameter was set and the power calculated over a range of concentrations from 0 to 99.5% mortality of the susceptible strain; maximum power was recorded. Six series were done to see whether relationships observed were consistent. As shown in Table 1 , the maximum power depends on the test statistic. As expected MaxPower was higher in all cases when the Z test statistic was used. However, the effect was small, especially at very high powers. The dose producing MaxPower, d offl , remained constant for the two test statistics (a result that statistical theory can show will always be true).
Effect of Toxicological Factors. The first toxicological factor that we examined was slope, the reciprocal of sigma. 'oNe investigated the effect of slope on power by examining changes over the entire range of doses at a given slope (Fig. 1) . The conditions for this test were n = 200; n. = H t = 100; ~ ~ 1.0; p ~ 0.05; and ' Y ~ 0.90. Slopes ranged from 2.5 to 5.5. Slope had a distinct effect on power (Fig. 1) . Three important trends in this figure are apparent. First, the test's power increased with higher slopes. For example, at the dose producing 95% mortality of the susceptible strain, power is 0.66 for a slope of 5,5 and 0.20 for a slope of 2.5. The second important trend was the consistent decrease in the power between the optimal dose and 100% mortality in the susceptible strain. This decrease was primarily due to the fact that fewer susceptible individuals survived the dose. Consequently, the statistical power of the test was reduced. This decrease in power suggests that the accepted procedure of establishing a discriminating dose of twice or four times the LDw or LDw9 will actually sometimes cause the wrong conclusion to be made whether resistance exists in the test population. The third trend is that as slope increases, so does the optimal dose. In these calculations, the optimal dose ranged from 89.0 for a ..,
.., slope of 2.5 to 98.1 for a slope of 5,5. This means that the optimal dose for conducting diagnostic dose tests depends upon the variables unique to that system. The parameter /:j. is directly related to the resistance factor (the ratio of the LDm of the fully resistant strain to the LD50 of the susceptible strain). In our model, all values were transformed so thai 6. = 1. 0 would actually correspond with a resistance factor of 10.0 when the LD:so's were based on tht logarithm of dose.
Delta had a large effect on power (Fig. 2) , Th, conditions of this test were P = 0.01; n = 2,000; n = n, = 1000; ' Y ~ 0.9; and slope ~ 3.0. At low ~ power remained low. Under the conditions of thi test, an apparent threshold existed above which th~ power increased dramatically. This occurred whel /:j. increased from 1 to 2 (Fig. 2) . Power decrease( as dose approached 100% susceptible mortality i the same manner as was seen in Fig. 1 except whe: resistance equaled 10,000 (~ ~ 4.0). Effect of Genetic Factors on Power. We define p as the frequency of the resistance gene in th test population. All parameters were held constar as before and the frequency of the resistance gen in the test population was then incrementall changed. The initial parameters for Fig. SA weI slope ~ 3.00; 11 ~ 200; n, ~ n, ~ 100; ~ = 2.0; ' Y 0.5. Hardy-\>Yeinberg equilibrium was assumel \>Ye also ran a number of tests and analyses extensions of the parameters already mention~ (slope and 6.). In these additional tests, we set tl resistance gene frequency equal to 0.01, 0.05, ' 0.10 and calculated :~vIaxPower for a series of slop (Fig. 3B) or ~ (Fig, 3C ). Conditions were set follows for slope effects: 11 = 2,000; fl. = fl t = 1,DC ~ ~ 1.0; and 'Y ~ 0.90. We chose the same ran of realistic slopes as in Fig. 1 . Frequency of t resistance gene played a major role in determini' the power. \>Vhen power was plotted against d( for three frequencies (Fig. 3A) , we found that t relationship between power and dose was simi' to that previously seen for changes in the slope a resistance level. As dose increased, power increas until MaxPower was reached, after which PO\1 decreased as the dose approached 100% suscepti1
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). ,"Ve chose the same range in Fig. L Frequency of the I a major role in determining ver was plotted against dose ( Fig. 3A) , we found that the power and dose was similar I for changes in the slope and ;e increased, power increased reached, after which power lpproached 100% susceptible Table 1 ) that as the frequency of the resistance gene increases, the optimal dose decreases.
MaxPower increases as slope increases for three different resistance gene frequencies (Fig. 3B) . This figure suggests that the dose~response line should have as high a slope as possible. A low slope will severely limit accuracy of a test. Fig. 3C demonstrates the effects of increasing resistance levels. For high resistance levels> 100 (Le., 6> 2.0), slight increases in the frequency of the resistance gene will rapidly increase the accuracy of the test. This figure also shows that, under some conditions, the maximal chance the diagnostic dose would have of detecting resistance is unacceptably low. "Vhen P = 0.01, MaxPower reached a plateau at 0.38 and at p ~ 0.05 it reached a plateau at 0.94 (Fig. 3e) . In Fig. 3D , the relationship between proportion resistant and MaxPower at different resistance levels is shown. The results in this figure reiterate the findings in Fig. 2 ; as resistance increases, so does the probability of detecting it with a diagnostic dose test. Fig. 3A -D indicate that gene frequency can play a major role in determining the potential to discover resistance. When gene frequency changes slightly, a large change in the power can occur under some conditions. \Vhy power increases as gene frequency increases seems intuitively obvious, ,"Vhen the frequency of resistant individuals increases in a population, the number of survivors from the test population will increase concomitantly. The larger the sample size, the better the statistical accuracy will be. Decreased accuracy can be explained by fewer susceptible survivors being available for calculating the X2 value.
The second genetic component we investigated was dominance. For simplicity of calculations, we used a factor called 'Y instead of the traditional degree of dominance (D) of Stone (1968) . Instead of ranging from -1 to 1 like D, 'Y ranges from 0 to 1. A value of 0 indicates complete recessiveness of the trait, whereas 0.5 and 1.0 indicate intermediate and complete dominance, respectively. D and'Y are linearly related as shown in equation 1:
The degree of dominance of resistance influences accuracy of diagnostic dose tests in much the same manner as the parameters previously examined (Fig.  4) . The conditions of this test were P = 0.05; 11 = 2,000; fl, = fl, = 1,000; slope = 3.0; and'" = 1.0. Fig. 4B shows the relationship between MaxPower, 'Y, .and P. This figure reiterates earlier results that showed increasing the gene frequency results in a higher power. It also demonstrates the advantage of having a dominant trait. To obtain a value of power of 0.9 (a reasonable level of accuracy in a test), the recessive trait in this example must be present at about three times the frequency of a dominant one (Fig. 4B) .
Effect of Operational Factors on Power. Sample size is one of the most important considerations in designing any experiment. In diagnostic dose tests, sample size depends on the number of susceptible insects (n,) and the number of insects from the test strain (nJ 'vV e examined the relationship between sample size and power when n. and HI were equal, and the effect of changing the ratio of susceptible to resistant insects. Results of calculations in which 11 (=n, + HI) varied from 200 to 2,000 and 111 and n, were equal are shown in Fig. SA . Other parameters were set at P = 0.05, 6. = LO, ' Y = 0.9, and slope = 3.0. Trials run with differing sample sizes produced results analogous to those seen earlier, i.e., power peaked at dq>1 and was higher for increasing sample sizes (Fig. SA) . Under these conditions, MaxPower increased from approximately 0.293 when only 200 individuals were tested to approximately 0.966 for 2,000 individuals. This result seems intuitively obvious. As sample size increases, so does the statistical accuracy of the test The optimal dose was unaffected by changing tll€ sample size. Roush & Miller (1986) suggested that testing, large number of susceptible insects would providt a better estimate of the true dose being used. Thi raised the question of whether changing the ratil of susceptible to resistant insects might also affec power. As shown in Fig. 5B , an optimal ratio existt but it becomes important only as power become relatively large. In the calculations when P = o. OJ power changed very little over a large range 0 ratios. \-Vhen P = 0.05, power decreased relativel uniformly. Slight departures from the 1:1 ratio di, not drastically decrease power. \-Vhen many mor insects of either type were tested, power was lOWE than it would have been had roughly equal nun bers been tested. The highest power occurred whe .4
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. f whether changing the ratio 5tant insects might also affect 'ig. 5B, an optimal ratio exists, rtant only as power becomes e calculations when P = 0.01, . little over a large range of 5, power decreased relatively Jartures from the 1:1 ratio did Ise power. \-Vhen many more were tested, power was lower leen had roughly equal nUffihighest power occurred when The magnitude of the differ-'en a Ll and a 11:9 ratio was rsus 0.795 for P ~ 0.05). The that, to have a test with the maximum power, researchers should test slightly more insects from the susceptible strain than insects from the test population.
Examples from Published Data
This kind of analysis requires dose-response data for susceptible, fully resistant, and heterozygous strains. Knowing the resistance factor, slope, and dominance, the researcher can then alter the remaining variables to determine the optimum dose, the frequency of the resistance gene necessary in the population to he detectable, and the number of insects that must he tested. The results of this kind of analysis have been presented in Table 2 . Published values of the level of resistance, slope of the dose-response line, and-dominance ('Y) were used as starting points. PO\\rer was calculated for three resistance gene frequencies (0.01, 0.05, and 0.10) based on testing either 100 or 1,000 susceptible and test insects. The resulting maximum power and dose are listed. ' As described earlier, optimal dose and total sample were unrelated since the dose at which maximum power occurs remains constant despite changes in total sample size. Data from the work on Bacilius tlwringiensis (Berliner) resistance in Indianmeal moth, Plodia interpunctelia (Hubner), by McGaughey & Beeman (1988) suggest that use of diagnostic dose tests for monitoring resistance will not be very effective until the resistance gene reaches fairly high levels. Table 2 illustrates this point. Maximum power will reach the 0.95 power level when n = 2,000 and the resistance gene frequency is between 0.05 and 0.10. The best dose to use kills 85.0% of the susceptible strain. The situation would be even bleaker for monitoring resistance to pyrethrins in Sitophilus granarills (L.). known that the gene frequency in the population is very high, (i.e., > 10%), the range of doses that will produce power of 0.999 is large (from 60.0 to 99.5%).
Conclusions
Diagnostic dose tests for monitoring resistance must be used with caution. Our results have shown relationships between various factors and how they influence the power of a diagnostic dose to correctly determine whether resistance exists in a population. Our model, which was designed to calculate the optimal dose to use in such experiments, revealed seven factors that interacted to influence the power. These could be conveniently classified as toxicological, genetic, or operational. As each factor changed, so did power but to varying degrees. The optimal dose increased as slope, resistance level, and dominance increased. The optimal dose decreased as resistance frequency increased and was unaffected by changes in sample size.
\Nhat does this analysis mean for those currently using or thinking of using diagnostic doses? It does not mean that all diagnostic dose experiments will produce incorrect results. Should such a test produce a significant difference in mortality between a susceptible and field strain, then this work is extraneous. There is a trend to conduct diagnostic dose tests in which the dose is chosen rather arbitrarily by multiplying the LDw or LDw.g by a factor of two or three (Suckling et al. 1987 , Subramanyam et al. 1989 . Clearly this strategy will result in the failure to detect resistance under some circumstances.
Application of this analysis in cases where resistance is not indicated would be interesting. An after-the-fact analysis of the test conditions might reveal whether the chances of detecting resistance had been high. If so, the original conclusion of there being no resistance in the field population would be strengthened. The true value of this kind of analysis probably resides in its ability to predict a priori the best dose to use in such assays and how likely the test is to reveal differences if they exist. The results presented here stress the need to find improved systems to monitor resistance in its early stages. Such systems might be derived from dose~ response procedures, such as the use of two or three doses that kill between 50 and 95% of the susceptible strain or from improvements in molecular biology technology in developing probes for resistance. The contents of the attached document are copyrighted works. You have secured permission to use this document for the following purpose: Permission to use 1 copy in US for the following use: "Internal General Business Use". You have not secured permission through Infotrieve, Inc. for any other purpose but may have other rights pursuant to other arrangements you may have with the copyright owner or an authorized licensing body. To the extent that a publisher or other appropriate rights-holder has placed additional terms and conditions on your use of this document, such terms and conditions are specified herein under "Copyright Terms". If you need to secure additional permission with respect to this content, please purchase the appropriate permission via the Mobile Library.
